Literature DB >> 27386427

Heterogeneity and Subclassification of Barcelona Clinic Liver Cancer Stage B.

M Kudo1.   

Abstract

Entities:  

Year:  2016        PMID： 27386427      PMCID： PMC4906422          DOI： 10.1159/000367768

Source DB:  PubMed          Journal:  Liver Cancer        ISSN： 1664-5553            Impact factor:   11.740


× No keyword cloud information.
  23 in total

1.  Surgical and Locoregional Therapy of HCC: TACE.

Authors:  Masakatsu Tsurusaki; Takamichi Murakami
Journal:  Liver Cancer       Date:  2015-07-10       Impact factor: 11.740

2.  Evidence-based Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2013 update (3rd JSH-HCC Guidelines).

Authors:  Norihiro Kokudo; Kiyoshi Hasegawa; Masaaki Akahane; Hiroshi Igaki; Namiki Izumi; Takafumi Ichida; Shinji Uemoto; Shuichi Kaneko; Seiji Kawasaki; Yonson Ku; Masatoshi Kudo; Shoji Kubo; Tadatoshi Takayama; Ryosuke Tateishi; Takashi Fukuda; Osamu Matsui; Yutaka Matsuyama; Takamichi Murakami; Shigeki Arii; Masatoshi Okazaki; Masatoshi Makuuchi
Journal:  Hepatol Res       Date:  2015-01       Impact factor: 4.288

3.  Subclassification of Barcelona Clinic Liver Cancer B and C hepatocellular carcinoma: A cohort study of the multicenter registry database.

Authors:  Sangheun Lee; Beom Kyung Kim; Kijun Song; Jun Yong Park; Sang Hoon Ahn; Seung Up Kim; Kwang-Hyub Han; Do Young Kim
Journal:  J Gastroenterol Hepatol       Date:  2016-04       Impact factor: 4.029

Review 4.  Subclassification of BCLC B Stage Hepatocellular Carcinoma and Treatment Strategies: Proposal of Modified Bolondi's Subclassification (Kinki Criteria).

Authors:  Masatoshi Kudo; Tadaaki Arizumi; Kazuomi Ueshima; Toshiharu Sakurai; Masayuki Kitano; Naoshi Nishida
Journal:  Dig Dis       Date:  2015-10-21       Impact factor: 2.404

5.  Dense accumulation of lipiodol emulsion in hepatocellular carcinoma nodule during selective balloon-occluded transarterial chemoembolization: measurement of balloon-occluded arterial stump pressure.

Authors:  Toshiyuki Irie; Masashi Kuramochi; Nobuyuki Takahashi
Journal:  Cardiovasc Intervent Radiol       Date:  2012-09-21       Impact factor: 2.740

6.  Hepatocellular carcinoma in Child-Pugh C cirrhosis: prognostic factors and survival benefit of nontransplant treatments.

Authors:  Masatoshi Kudo; Yukio Osaki; Takashi Matsunaga; Hiroshi Kasugai; Hiroko Oka; Toshihito Seki
Journal:  Dig Dis       Date:  2013-11-21       Impact factor: 2.404

Review 7.  JSH Consensus-Based Clinical Practice Guidelines for the Management of Hepatocellular Carcinoma: 2014 Update by the Liver Cancer Study Group of Japan.

Authors:  Masatoshi Kudo; Osamu Matsui; Namiki Izumi; Hiroko Iijima; Masumi Kadoya; Yasuharu Imai; Takuji Okusaka; Shiro Miyayama; Kaoru Tsuchiya; Kazuomi Ueshima; Atsushi Hiraoka; Masafumi Ikeda; Sadahisa Ogasawara; Tatsuya Yamashita; Tetsuya Minami; Koichiro Yamakado
Journal:  Liver Cancer       Date:  2014-10       Impact factor: 11.740

Review 8.  Image-Guided Ablation of Malignant Liver Tumors: Recommendations for Clinical Validation of Novel Thermal and Non-Thermal Technologies - A Western Perspective.

Authors:  Riccardo Lencioni; Thierry de Baere; Robert C Martin; Charles W Nutting; Govindarajan Narayanan
Journal:  Liver Cancer       Date:  2015-10-21       Impact factor: 11.740

Review 9.  Heterogeneity of patients with intermediate (BCLC B) Hepatocellular Carcinoma: proposal for a subclassification to facilitate treatment decisions.

Authors:  Luigi Bolondi; Andrew Burroughs; Jean-François Dufour; Peter R Galle; Vincenzo Mazzaferro; Fabio Piscaglia; Jean Luc Raoul; Bruno Sangro
Journal:  Semin Liver Dis       Date:  2013-02-08       Impact factor: 6.115

10.  Management of hepatocellular carcinoma: an update.

Authors:  Jordi Bruix; Morris Sherman
Journal:  Hepatology       Date:  2011-03       Impact factor: 17.425
View more
  13 in total

1.  The Overall Survival of Patients with Hepatocellular Carcinoma Correlates with the Newly Defined Time to Progression after Transarterial Chemoembolization.

Authors:  Tadaaki Arizumi; Kazuomi Ueshima; Mina Iwanishi; Tomohiro Minami; Hirokazu Chishina; Masashi Kono; Masahiro Takita; Norihisa Yada; Satoru Hagiwara; Yasunori Minami; Hiroshi Ida; Yoriaki Komeda; Mamoru Takenaka; Toshiharu Sakurai; Tomohiro Watanabe; Naoshi Nishida; Masatoshi Kudo
Journal:  Liver Cancer       Date:  2017-05-09       Impact factor: 11.740

2.  A Changing Paradigm for the Treatment of Intermediate-Stage Hepatocellular Carcinoma: Asia-Pacific Primary Liver Cancer Expert Consensus Statements.

Authors:  Masatoshi Kudo; Kwang-Hyub Han; Sheng-Long Ye; Jian Zhou; Yi-Hsiang Huang; Shi-Ming Lin; Chung-Kwe Wang; Masafumi Ikeda; Stephen Lam Chan; Su Pin Choo; Shiro Miyayama; Ann Lii Cheng
Journal:  Liver Cancer       Date:  2020-05-13       Impact factor: 11.740

3.  A New Treatment Option for Intermediate-Stage Hepatocellular Carcinoma with High Tumor Burden: Initial Lenvatinib Therapy with Subsequent Selective TACE.

Authors:  Masatoshi Kudo
Journal:  Liver Cancer       Date:  2019-09-18       Impact factor: 11.740

Review 4.  Clinical Utility of Albumin Bilirubin Grade as a Prognostic Marker in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization: a Systematic Review and Meta-analysis.

Authors:  Gauri Mishra; Ammar Majeed; Anouk Dev; Guy D Eslick; David J Pinato; Hirofumi Izumoto; Atsushi Hiraoka; Teh-Ia Huo; Po-Hong Liu; Philip J Johnson; Stuart K Roberts
Journal:  J Gastrointest Cancer       Date:  2022-05-30

5.  Ramucirumab for Patients with Intermediate-Stage Hepatocellular Carcinoma and Elevated Alpha-Fetoprotein: Pooled Results from Two Phase 3 Studies (REACH and REACH-2).

Authors:  Masatoshi Kudo; Richard S Finn; Manabu Morimoto; Kun-Ming Rau; Masafumi Ikeda; Chia-Jui Yen; Peter R Galle; Josep M Llovet; Bruno Daniele; Ho Yeong Lim; David W McIlwain; Reigetsu Yoshikawa; Kenichi Nakamura; Kun Liang; Chunxiao Wang; Paolo Abada; Ryan C Widau; Andrew X Zhu
Journal:  Liver Cancer       Date:  2021-07-12       Impact factor: 11.740

6.  Conditional Survival Estimates Improve Over Time for Patients with Hepatocellular Carcinoma: An Analysis for Nationwide Korea Cancer Registry Database.

Authors:  Jae Seung Lee; In Rae Cho; Hye Won Lee; Mi Young Jeon; Tae Seop Lim; Oidov Baatarkhuu; Do Young Kim; Kwang-Hyub Han; Jun Yong Park
Journal:  Cancer Res Treat       Date:  2019-02-12       Impact factor: 4.679

7.  Transarterial radioembolization in patients with hepatocellular carcinoma of intermediate B2 substage.

Authors:  Alberta Cappelli; Paloma Sangro; Cristina Mosconi; Iris Deppe; Eleonora Terzi; Jose I Bilbao; Macarena Rodriguez-Fraile; Caterina De Benedittis; Jens Ricke; Rita Golfieri; Bruno Sangro
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-09-12       Impact factor: 9.236

Review 8.  Patients with Barcelona Clinic Liver Cancer Stages B and C Hepatocellular Carcinoma: Time for a Subclassification.

Authors:  Rita Golfieri; Irene Bargellini; Carlo Spreafico; Franco Trevisani
Journal:  Liver Cancer       Date:  2018-06-27       Impact factor: 11.740

Review 9.  Identifying Clonal Origin of Multifocal Hepatocellular Carcinoma and Its Clinical Implications.

Authors:  Di-Yang Xie; Hong-Kai Fan; Zheng-Gang Ren; Jia Fan; Qiang Gao
Journal:  Clin Transl Gastroenterol       Date:  2019-02       Impact factor: 4.488

10.  Significance of liver resection for intermediate stage hepatocellular carcinoma according to subclassification.

Authors:  Masateru Yamamoto; Tsuyoshi Kobayashi; Masakazu Hashimoto; Shintaro Kuroda; Tomokazu Kawaoka; Hiroshi Aikata; Kazuaki Chayama; Hideki Ohdan
Journal:  BMC Cancer       Date:  2021-06-05       Impact factor: 4.430
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.